Effective Date of Rule: Thirty-one days after filing.
Purpose: To amend WAC 260-70-630, specifically subsection (3) to clarify that the concentration of nandrolone in intact males is 45 nanograms of nandrolone metabolites per milliliter of urine.
Citation of Existing Rules Affected by this Order: Amending WAC 260-70-630.
Statutory Authority for Adoption: RCW 67.16.020 and 67.16.040.
Adopted under notice filed as WSR 08-13-030 on June 10, 2008.
Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 0, Amended 0, Repealed 0.
Number of Sections Adopted at Request of a Nongovernmental Entity: New 0, Amended 0, Repealed 0.
Number of Sections Adopted on the Agency's Own Initiative: New 0, Amended 1, Repealed 0.
Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 0, Repealed 0.
Number of Sections Adopted Using Negotiated Rule Making: New 0, Amended 1, Repealed 0; Pilot Rule Making: New 0, Amended 0, Repealed 0; or Other Alternative Rule Making: New 0, Amended 0, Repealed 0.
Date Adopted: August 14, 2008.
R. J. Lopez
AMENDATORY SECTION(Amending WSR 08-05-091, filed 2/15/08, effective 6/1/08)
WAC 260-70-630 Threshold levels. (1) Permitted medications.
(a) The following quantitative medications are permissible in test samples up to the stated concentrations:
Procaine - 25 ng/ml urine
Benzocaine - 50 ng/ml urine
Mepivacaine - 10 ng/ml urine
Lidocaine - 50 ng/ml urine
Bupivacaine - 5 ng/ml urine
Clenbuterol - 25 pg/ml serum or plasma
Acepromazine - 25 ng/ml urine
Promazine - 25 ng/ml urine
Salicylates - 750,000 ng/ml urine
Albuterol - 1 ng/ml urine
Pyrilamine - 50 ng/ml urine
Theobromine - 2000 ng/ml urine
(b) The official urine or blood test sample may not contain more than one of the above substances, including their metabolites or analogs, and may not exceed the concentrations established in this rule.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Caffeine - 100 ng/ml serum or plasma
Benzoylecgonine - 50 ng/ml urine
Morphine Glucuronides - 50 ng/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
Stanozolol (Winstrol) - 1 ng/ml urine in all horses regardless of sex.
Boldenone (Equipoise) - 15 ng/ml urine in intact males. No level is permitted in geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3&bgr;,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.
[Statutory Authority: RCW 67.16.020 and 67.16.040. 08-05-091, § 260-70-630, filed 2/15/08, effective 6/1/08; 06-09-009, § 260-70-630, filed 4/10/06, effective 5/11/06; 05-07-067, § 260-70-630, filed 3/11/05, effective 4/11/05. Statutory Authority: RCW 67.16.020. 04-05-095, § 260-70-630, filed 2/18/04, effective 3/20/04; 03-11-019, § 260-70-630, filed 5/12/03, effective 6/12/03. Statutory Authority: RCW 67.16.040. 96-10-001, § 260-70-630, filed 4/17/96, effective 5/18/96.]